30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)

30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)
Acute Granulocytic Leukemia AML
About 95% or more of APL patients have a PML/RARA fusion gene, which accounts for about 9% of all AML. hallmarks of M3 typing with a good prognosis. Guidance on targeted drug therapy (all-trans retinoic acid and arsenic trioxide) and evaluation of efficacy.